No abstract available
MeSH terms
-
Adalimumab
-
Analgesics / adverse effects*
-
Analgesics / therapeutic use
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antidepressive Agents / adverse effects*
-
Antidepressive Agents / therapeutic use
-
Biological Products / therapeutic use
-
Cytochrome P-450 Enzyme System / metabolism
-
Diabetes Mellitus, Type 1 / complications
-
Diabetic Neuropathies / complications
-
Diabetic Neuropathies / drug therapy
-
Drug Interactions
-
Duloxetine Hydrochloride
-
Female
-
Humans
-
Pregabalin
-
Psoriasis / complications*
-
Psoriasis / drug therapy
-
Thiophenes / adverse effects*
-
Thiophenes / therapeutic use
-
Young Adult
-
gamma-Aminobutyric Acid / adverse effects
-
gamma-Aminobutyric Acid / analogs & derivatives*
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
Analgesics
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal, Humanized
-
Antidepressive Agents
-
Biological Products
-
Thiophenes
-
Pregabalin
-
gamma-Aminobutyric Acid
-
Cytochrome P-450 Enzyme System
-
Duloxetine Hydrochloride
-
Adalimumab